Lisa M. Goetz, LPCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 1702 E Main St Ste 101, Mandan, ND 58554 Phone: 701-751-8060 Fax: 701-751-8060 |
Candace Rivinius, LPCC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1702 E Main St Ste 101, Mandan, ND 58554 Phone: 701-751-8060 Fax: 701-751-8060 |
Kathleen Schmaltz, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 314 W Main St, Mandan, ND 58554 Phone: 701-663-2122 Fax: 701-663-7521 |
Michelle Lee Frei, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 100 6th Ave Se, Mandan, ND 58554 Phone: 701-663-8228 Fax: 701-663-0912 |
Darrel G Lindensmith, MA MS LPC Counselor - Pastoral Medicare: Not Enrolled in Medicare Practice Location: 3030 Old Red Trail St., Mandan, ND 58554 Phone: 701-391-9131 Fax: 701-663-2763 |
Jeanne Marie Hettich Farnsworth, LPCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 103 Shady Acres St Ne, Mandan, ND 58554 Phone: 605-281-0528 Fax: 701-255-4495 |
Sloane Floberg, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1702 E Main St Ste 101, Mandan, ND 58554 Phone: 701-751-8060 Fax: 701-751-8060 |
Elizabeth Smith, LMSW Counselor Medicare: Accepting Medicare Assignments Practice Location: 102 Mandan Ave, Mandan, ND 58554 Phone: 701-667-5000 |
News Archive
Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, according to new analysis from the RAND Corporation.
When you imagine a visit to a natural history museum, the first thing that springs to mind could be dinosaur bones or taxidermized animals.
A new pilot study is getting underway in Rhode Island aimed at improving depression in nursing home rehabilitation patients, all through telemedicine. Geriatric mental health specialists from Rhode Island and The Miriam hospitals will work with patients in the Evergreen House Nursing Home and Rehabilitation Center in East Providence to test the program.
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
› Verified 2 days ago